Virtual Crypto Technologies Inc. (VRCP) Leads Breakthrough

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
548
Virtual Crypto Technologies Inc. (VRCP) Leads Breakthrough in Cryptocurrency ATMs, Enabling Rapid Crypto-to-Cash Transactions

- ‘Very high accuracy’ platform cuts cryptocurrency/virtual coin transaction time by deploying predictive algorithm
- Product rollout benefitting distribution MOU in Turkey and Cyprus, with Nigeria option
- Market for cryptocurrency-enabled ATMs expected to have CAGR of 45.8 percent through 2025

The growth of blockchain-enabled currencies worldwide as a way to complete financial transactions with fewer regulatory hurdles than those imposed by traditional banking solutions exemplifies a modern-day movement to empower people monetarily, but the fintech industry has its own set of challenges. In response to the transaction time delays inherent in the need to secure a cryptocurrency agreement, Virtual Crypto Technologies Inc. (OTCQB: VRCP) has rolled out a proprietary algorithmic platform that dramatically speeds up the verification process, which in turn allows parties to negotiate trades at real-time rates without concerns that the rate will become much more unfavorable by the time the transaction is concluded.

Virtual Crypto Technologies Inc., through wholly owned Israeli subsidiary Virtual Crypto Technologies Ltd., develops products that make cryptocurrencies accessible to the public through payment solutions that benefit businesses and consumers alike.

Virtual Crypto Technologies’ NetoBit product line attracted the attention of Israel-based oil refinery relocater Chiron Refineries Ltd. (TASE: CHR), which this year began to diversify its operations to include the “cryptocurrency accessibility” sector. Chiron inked a binding Memorandum of Understanding with Virtual Crypto in January that granted Chiron exclusive rights to distribute Virtual Crypto’s products in the territories of North Cyprus and Turkey (http://nnw.fm/MY7Gc), with an option to expand the distribution business into Nigeria within 12 months.

Chiron intends to market the technology to casino cashiers, ATM operators, currency exchange offices and coffee shops for starters, offering a non-bank means of completing financial transactions using the cryptocurrencies at a rapid completion rate.

“We decided to enter the cryptocurrency sector as we envision a significant increase in market participation and believe that there is a real opportunity to generate substantial revenues by making cryptocurrency accessible and understandable to the mainstream consumer,” Chiron CEO Rony Kuperberg stated in a recent news release (http://nnw.fm/8uAMa).

Virtual Crypto’s combination of Application Programming Interfaces and mobile applications supports its products’ deployment in ATMs, PCs and mobile devices such as tablets and cell phones. The global market for ATMs that allow transactions in cryptocurrencies is forecast to increase from its 2017 valuation of $14 million to surpass $285.1 million by 2025, experiencing a CAGR of 45.8 percent, according to market researcher Coherent News (http://nnw.fm/N867q), but only about a third of the machines currently allow two-way trades.

Virtual Crypto states that NetoBit Trader’s ability to drastically reduce the transaction time is largely due to a “very high accuracy” predictive algorithm that establishes the likelihood of a successful transaction long before it is actually completed. Whereas a typical transaction may take from 10 minutes to 24 hours to complete and close the blockchain module, NetoBit’s system establishes the probability of validation by multiple miners, even as the miner validation process is taking place (http://nnw.fm/ZtR0U). The platform also addresses common liquidity problems by connecting with multiple exchanges, allowing the system to divide a single payment across exchanges and thereby create more of a resource than a single exchange can provide.

As Virtual Crypto has rolled out phases of its product, Chiron has responded with phased payments, announcing the completion of an initial $50,000 payment followed by another $50,000 executed in transferred stock shares thus far.

“Our collaboration with Chiron continues to progress at an accelerated pace, largely driven by their desire to establish an early foothold in the Turkish and Cypriot markets,” Virtual Crypto CEO Alon Dayan stated in one of the news releases. “Preliminary testing of the modified software was extremely successful and we expect to maintain this momentum, providing them with a next version we expect to be released in the following weeks.”

For more information, visit the company’s website at www.Virtual-Crypto.com

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

ViewBix Inc. (VBIX) Stock Research Links

VBIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 3

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 10

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading

Top 5 Most Recently Viewed Articles

Microbot Medical Secures $13 Million in Recent Offering

Updated Category News Views 92

Microbot Medical Makes Strategic Move with $13 Million Offering Microbot Medical Inc. (NASDAQ: MBOT) has recently taken an important step to elevate its operations by entering into definitive agreements to sell 6,103,289 shares of its common stock at a price of $2.13 per share. This registered direct offering, priced at-the-market under Nasdaq rules, underscores the...

Continue Reading
Evolv Technologies Faces Class Action Lawsuit: Know Your Rights

Updated Category News Views 651

Understanding the Evolv Technologies Holdings Class Action Recent developments have raised significant concerns among shareholders of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV). A class action lawsuit is currently in progress, prompting investors to scrutinize the implications of false statements made by the company. The allegations revolve around misleading...

Continue Reading
Rhino Rescue Unveils Innovative First Aid Kits for Adventurers

Updated Category News Views 117

Rhino Rescue Launches Innovative Products for Outdoor Safety Rhino Rescue has made a remarkable stride in enhancing outdoor safety with its new lineup of first aid kits targeted towards adventurers and everyday users alike. The release of the Rhino Rescue Mini First Aid Kit, along with home and camping-specific options, marks an exciting development in the company’s...

Continue Reading
RUSH's 2026 Tour: Celebrating Legacy and New Beginnings

Updated Category News Views 258

RUSH's 2026 Tour: A Celebration of Music and Legacy Geddy Lee and Alex Lifeson are set to celebrate over 50 years of RUSH's musical journey as they announce a special headline tour for 2026, named the Fifty Something Tour. This tour not only commemorates the incredible music and legacy of RUSH, but also pays tribute to their late drummer and lyricist Neil Peart, whose...

Continue Reading
BioSyent Inc. Announces Quarterly Dividend for Shareholders

Updated Category News Views 132

BioSyent Inc. Announces Quarterly Dividend for Shareholders MISSISSAUGA, Ontario — BioSyent Inc. (TSX Venture: RX) is thrilled to communicate that its Board of Directors has approved a quarterly dividend of $0.05 per common share. This dividend will be paid in Canadian Dollars on a specified date to shareholders who are on record, enhancing the company's ongoing...

Continue Reading